Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06914947 · ClinicalTrials.gov registry record
Brain Health Together: Development and Pilot Test
A clinical trial of Cognitive Impairment and Mild Cognitive Impairment (MCI), sponsored by University of California, San Francisco.
- Completed
- Registry status
- 16
- Enrollment target
- 1
- Study location
NCT06914947: Completed study of Cognitive Impairment and Mild Cognitive Impairment (MCI), sponsored by University of California, San Francisco.
NCT06914947 is a study of Cognitive Impairment and Mild Cognitive Impairment (MCI) that has completed, run by University of California, San Francisco. The registered enrollment target is 16 participants, below the 665-participant average among 105 other Cognitive Impairment trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06914947, a study of Cognitive Impairment and Mild Cognitive Impairment (MCI), has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- 16 participants
- Enrollment target
- 1
- Study location
Study Summary
The objectives of this study were to develop and pilot-test Brain Health Together (BHT), a 12-week, virtual-group program that combines our evidence-based, mind-body, group movement program with brain health education and coaching to reduce dementia risk through targeting modifiable risk factors among older adults with cognitive impairment.
Primary Outcome
To examine feasibility, the investigators tracked participant attendance, calculated as the mean±standard deviation (SD) of sessions completed by each participant.
Conditions Studied
Interventions
- BEHAVIORAL Brain Health Together
Study Locations (1)
California
- University of California, San Francisco - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2021-09-30 |
| Est. Completion | 2022-10-11 |
What the finished NCT06914947 record still lists
NCT06914947 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 16 participants, a relatively small participant target, below the 665-participant average among 105 other Cognitive Impairment trials with a reported enrollment target (98% lower).
The record links to 3 conditions, with Cognitive Impairment appearing as the primary indexed condition, and to 1 intervention - of which Brain Health Together is the first listed.
NCT06914947 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT06914947 about?
NCT06914947 is a clinical study titled "Brain Health Together: Development and Pilot Test". The objectives of this study were to develop and pilot-test Brain Health Together (BHT), a 12-week, virtual-group program that combines our evidence-based, mind-body, group movement program with brain health education and coaching to reduce dementia risk through targeting modifiable risk factors amo...
What is the current status of trial NCT06914947?
This trial is currently completed. The enrollment target is 16 participants. The study started on 2021-09-30. Estimated completion is 2022-10-11.
What conditions does trial NCT06914947 study?
This clinical trial studies the following conditions: Cognitive Impairment, Mild Cognitive Impairment (MCI), Subjective Cognitive Decline.
What interventions are being tested in trial NCT06914947?
The interventions under investigation include: Brain Health Together (BEHAVIORAL).
Who is sponsoring clinical trial NCT06914947?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06914947 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cognitive Impairment
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06914947's enrollment target sits among peer trials
16 99th of 105 higher than 7 of 105 other Cognitive Impairment trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cognitive Impairment trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Investigating the Effects of Wearable Robotic Exoskeleton for Improving Mobility and Cognition in Persons With MS
RECRUITING · NA
-
Mind Your Heart-II
RECRUITING · NA
-
Biomarker Exploration in Aging, Cognition and Neurodegeneration
RECRUITING · Phase 3
-
Transcranial Direct Current Stimulation and Rehabilitation to Ameliorate Impairments in Neurocognition After Stroke
RECRUITING · NA
-
Impact of a Multimodal Lifestyle Intervention on Dementia Risk Factors and Attitude Related to Dementia Risk: A Logistical Pilot Study
RECRUITING · NA
-
Essential Fats For Enhancing Cognitive Thinking (EFFECT) Study
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02422641 · 16 participants · Phase 2
Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis
- NCT02851758 · 16 participants · NA
Transplantation of Autologously Derived Mitochondria Following Ischemia
- NCT03291028 · 16 participants
Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma
- NCT03425526 · 16 participants · Phase 1
Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI